antibody-peptide The field of biopharmaceutical analysis is continually evolving, driven by the need for precise and sensitive methods to quantify complex protein therapeutics, particularly antibodies. A significant advancement in this area is the development and widespread adoption of the antibody surrogate peptide quantification approach. This technique leverages the power of mass spectrometry, specifically liquid chromatography-tandem mass spectrometry (LC-MS/MS), to provide robust and reliable measurements of therapeutic proteins.
At its core, the surrogate peptide strategy involves identifying and quantifying a specific peptide fragment derived from the target protein. This peptide then serves as a proxy, or surrogate, for the entire protein molecule. The immense advantage lies in the ability to achieve highly sensitive and specific quantification of even trace amounts of therapeutic antibodies in complex biological matrices such as plasma or serum.Absolute quantitation of binding antibodies from clinical ... This is crucial for pharmacokinetic (PK) and pharmacodynamic (PD) studies, as well as for quality control during drug development and manufacturing.
Historically, quantifying intact therapeutic antibodies has presented significant challenges.Background: Different liquid chromatography tandem mass spectrometry (LC–MS/MS) methods have been published forquantificationof monoclonalantibodies(mAbs) ... Traditional immunoassays, while useful, can suffer from issues like cross-reactivity and limited dynamic range.Development and Validation of an LC–MS-Based ... The surrogate peptide approach, however, offers a distinct advantage by focusing on a unique proteolytic fragment. This method has become a cornerstone of MS-based protein quantification due to its inherent high sensitivity and specificity.
A key innovation in this field is the concept of a universal surrogate peptide作者:JR Fogh·2020·被引用次数:26—Investigating the utility of minimized sample preparation and high-resolution mass spectrometry forquantificationof mono- clonalantibodydrugs. J Pharm .... Researchers have identified peptides that are conserved across a broad range of human monoclonal antibodies (mAbs), particularly within the Fc region.Absolute quantitation of binding antibodies from clinical ... For instance, universal surrogate peptides found in the Fc region of most human mAb candidates are particularly valuable as they are typically absent from the proteomes of common laboratory animals, simplifying analysis in preclinical studies. These universal surrogates can be derived from specific antibody classes, such as a universal tryptic peptide from human IgG1, IgG3, and IgG4. This universality allows for a more generalized bioanalytical method, reducing the need for assay development for each individual antibodyAntibody-free workflows for protein quantification by LC-MS ....
The process typically begins with enzymatic digestion, often using trypsin, to break down the protein into smaller peptides. The selection of the appropriate surrogate peptide is a critical step, as the quality of the quantification data is solely dependent on this choice. The chosen peptide must be proteotypic, meaning it uniquely identifies the target protein. Furthermore, its abundance and detectability by LC-MS/MS are paramountRapid quantitation of therapeutic antibodies in animal plasma. Researchers often focus on peptides found in the constant regions of antibodies, as these are more conserved. For example, Rituximab and Trastuzumab contain constant regions of the $\gamma$1-chain and $\kappa$-chain of human antibodies, making them suitable targets for surrogate peptide selection.Generic Peptide Strategies for LC–MS/MS Bioanalysis of ...
Once the surrogate peptide is identified, its quantification is performed using LC-MS/MS.Development and Validation of an LC–MS-Based ... This technique separates the peptides based on their liquid chromatography retention times and then measures their mass-to-charge ratio and fragmentation patterns in the mass spectrometer. This allows for highly accurate and precise measurement of the surrogate peptide's abundance. Peptides of unknown sequence can be used for selective LC–MS quantification when coupled with appropriate enrichment strategies.
To further enhance accuracy and precision, internal standards are often employed.Absolute quantitation of binding antibodies from clinical ... These are typically stable isotope-labeled versions of the surrogate peptide, added to the sample at a known concentration. By comparing the signal of the endogenous surrogate peptide to that of the labeled internal standard, variations in sample preparation, digestion, and instrument performance can be effectively compensated for, leading to more robust quantitative results. This internal standardization is crucial for reliable quantification.LC-MS bioanalysis of proteins via the surrogate peptide ...
The development of antibody-free workflows for protein quantification by LC-MS is also an area of active research, aiming to reduce reliance on specific peptide antibodies for enrichment. However, peptide antibodies can still play a vital role in certain immuno-MS procedures, where they are used to capture the surrogate peptide before quantification by LC–MS/MS.
The surrogate peptide approach has proven invaluable for the quantitative bioanalysis of chimeric or humanized monoclonal antibodies from various biological matrices, including non-human plasma. This methodology facilitates the accurate determination of drug concentrations, enabling a deeper understanding of antibody behavior in vivo. The ability to perform rapid quantitation of therapeutic antibodies in animal plasma accelerates preclinical drug development.
In summary, antibody surrogate peptide quantification represents a significant leap forward in the bioanalytical sciences作者:MT Furlong·2017·被引用次数:2—This chapter describes the development and successful deployment of genericsurrogate peptide-based liquid chromatography-mass spectrometry (LC- .... Its reliance on the precise and sensitive detection of specific peptides via LC-MS/MS provides a powerful tool for researchers and developers working with antibody-based therapeutics. The ongoing refinement of surrogate peptide selection, the development of universal surrogates, and the integration of robust internal standardization strategies continue to enhance the accuracy and efficiency of protein quantification, ultimately contributing to the development of safer and more effective medicines. This analysis is a testament to the power of applying advanced peptide-based technologies to complex biological challengesThe use of generic surrogate peptides for the quantitative ....
Join the newsletter to receive news, updates, new products and freebies in your inbox.